Zacks Investment Research

Recent Articles

Lululemon’s EPS Expected to Climb: What LULU Stock Owners Should Know Ahead of Next Week’s Release

LULU possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Owners and prospective buyers of LULU stock should examine these factors.

Facebook, Apple, Amazon, or Netflix: Time to Buy a Few FAANG Stocks Again?

Should investors consider buying some FAANG stocks, such as Netflix stock, Facebook, Apple or Amazon?

ULTA Reporting After the Bell Today: Will ULTA Stock Remain a Retail Jewel?

ULTA stock has had some strong, positive catalysts, including ULTA's ability to meet the needs of its younger customers.

Nike Stock Is Outpacing the Market: What You Should Know

Nike stock closed yesterday at $83.48, gaining 1.77% from the previous trading session. NKE stock is also outpacing the market in early trading today.

Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?

Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.